732 related articles for article (PubMed ID: 32205473)
21. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems.
Oliva E; Amin MB; Jimenez R; Young RH
Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940
[TBL] [Abstract][Full Text] [Related]
22. Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
Pisacane A; Cascardi E; Berrino E; Polidori A; Sarotto I; Casorzo L; Panero M; Boccaccio C; Verginelli F; Benvenuti S; Dellino M; Comoglio P; Montemurro F; Geuna E; Marchiò C; Sapino A
Virchows Arch; 2023 Mar; 482(3):463-475. PubMed ID: 36346458
[TBL] [Abstract][Full Text] [Related]
23. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma.
Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ
Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954
[TBL] [Abstract][Full Text] [Related]
25. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
[TBL] [Abstract][Full Text] [Related]
26. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
27. American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.
Bellizzi AM; Montgomery EA; Hornick JL
Ann Diagn Pathol; 2020 Feb; 44():151419. PubMed ID: 31786484
[TBL] [Abstract][Full Text] [Related]
28. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Utility of SATB2 in Metastatic Krukenberg Tumors of the Ovary: An Immunohistochemical Study of 70 Cases With Comparison to CDX2, CK7, CK20, Chromogranin, and Synaptophysin.
Yang C; Sun L; Zhang L; Zhou L; Zhao M; Peng Y; Niu D; Li Z; Huang X; Kang Q; Jia L; Lai J; Cao D
Am J Surg Pathol; 2018 Feb; 42(2):160-171. PubMed ID: 28914716
[TBL] [Abstract][Full Text] [Related]
30. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry.
Bellizzi AM
Adv Anat Pathol; 2013 Sep; 20(5):285-314. PubMed ID: 23939147
[TBL] [Abstract][Full Text] [Related]
31. A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens.
Montezuma D; Azevedo R; Lopes P; Vieira R; Cunha AL; Henrique R
Virchows Arch; 2013 Dec; 463(6):749-54. PubMed ID: 24126803
[TBL] [Abstract][Full Text] [Related]
32. Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?
Scoazec JY
Ann Endocrinol (Paris); 2019 Jun; 80(3):163-165. PubMed ID: 31064659
[TBL] [Abstract][Full Text] [Related]
33. Merkel cell carcinoma with an unusual immunohistochemical profile.
Pilloni L; Manieli C; Senes G; Ribuffo D; Faa G
Eur J Histochem; 2009 Dec; 53(4):e33. PubMed ID: 22073365
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours.
Strickland S; Parra-Herran C
Histopathology; 2016 Jun; 68(7):977-87. PubMed ID: 26542609
[TBL] [Abstract][Full Text] [Related]
35. Hybrid model integrating immunohistochemistry and expression profiling for the classification of carcinomas of unknown primary site.
Centeno BA; Bloom G; Chen DT; Chen Z; Gruidl M; Nasir A; Yeatman TY
J Mol Diagn; 2010 Jul; 12(4):476-86. PubMed ID: 20558571
[TBL] [Abstract][Full Text] [Related]
36. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
Park SY; Kim BH; Kim JH; Lee S; Kang GH
Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593
[TBL] [Abstract][Full Text] [Related]
37. Problems with the diagnosis of metastatic neuroendocrine neoplasms. Which diagnostic criteria should we use to determine tumor origin and help guide therapy?
Koo J; Dhall D
Semin Diagn Pathol; 2015 Nov; 32(6):456-68. PubMed ID: 26573790
[TBL] [Abstract][Full Text] [Related]
38. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites.
Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ
Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273
[TBL] [Abstract][Full Text] [Related]
39. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
